(PhD, CEO and co-founder)

Dr. He is a medical diagnostics entrepreneur with significant expertise in EV isolation and molecular diagnostic assay development. He has received extensive training in business development through programs like TechCelerator, NIH I-Corps, LifeX Lab, and NSF I-Corps. During his tenure at Captis Diagnostics, he has focused on developing EV-based minimally invasive technology for human disease diagnosis, along with ddPCR and next-generation sequencing molecular diagnostic assays. Dr. He has authored over 50 publications, with 3675 citations on Google Scholar, and holds 1 issued patent with 5 patent applications.

(PhD, Principal Research Scientist)

Dr. Milosevic is an accomplished researcher and R&D scientist with extensive experience in epigenetics, biomarker discovery, and EV research. Her primary objective is to develop minimally invasive liquid biopsy tools as routine diagnostic tests for human disease. Over more than 15 years, she has acquired substantial expertise in her field and has authored 25 scientific publications. Dr. Milosevic has played various roles, from mentoring and supervising junior scientists to working both independently and collaboratively in research teams.